TY - JOUR
T1 - New rhenium complexes with ciprofloxacin as useful models for understanding the properties of [99mTc]-ciprofloxacin radiopharmaceutical
AU - Lecina, Joan
AU - Cortés, Pilar
AU - Llagostera, Montserrat
AU - Piera, Carlos
AU - Suades, Joan
N1 - Funding Information:
This research was supported by Dirección General de Investigación Científica y Técnica , Ministerio de Economía y Competitividad (Projects CTQ2007-63913 , BIO2009-12513-C02-02 and BIO2012-39682-C02-02 ) and by Grant SGR 2009/1106 from Generalitat de Catalunya .
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2014/7/1
Y1 - 2014/7/1
N2 - Rhenium complexes with the antibiotic ciprofloxacin have been prepared to be studied as models of technetium radiopharmaceuticals. With this aim, the new rhenium complexes 1 {[ReO(Cpf)2]Cl}, 2 {[ReO(CpfH) 2]Cl3} and 3 {fac-[Re(CO)3(H 2O)(Cpf)]} with ciprofloxacin (CpfH = ciprofloxacin; Cpf = conjugated base of ciprofloxacin) have been synthesised and characterised by elemental analyses, IR, NMR (1H, 19F and 13C CP-MAS) spectroscopy, as well as MS measurements. All spectroscopic data are consistent with the coordination of ciprofloxacin in all these complexes through the carbonyl and the carboxylate oxygen atoms with the formation of a six member chelate ring. The study of a Tc-ciprofloxacin solution by ESI-MS reveals the presence of [TcO(Cpf)2]+ cations, which agrees with the hypothesis that complexes 1 and 2 can be seen as model rhenium complexes of this radiopharmaceutical. Antimicrobial and DNA gyrase inhibition studies performed with complexes 2 and 3 have shown a very similar behaviour between complex 2 and the free antibiotic, whereas complex 3 exhibit a lower antimicrobial activity. Based on a joint analysis of the data reported in the literature and the chemical and biological results obtained in this study, a tentative proposal to explain some aspects of the behaviour of Tc-ciprofloxacin radiopharmaceutical has been made. © 2014 Elsevier Ltd. All rights reserved.
AB - Rhenium complexes with the antibiotic ciprofloxacin have been prepared to be studied as models of technetium radiopharmaceuticals. With this aim, the new rhenium complexes 1 {[ReO(Cpf)2]Cl}, 2 {[ReO(CpfH) 2]Cl3} and 3 {fac-[Re(CO)3(H 2O)(Cpf)]} with ciprofloxacin (CpfH = ciprofloxacin; Cpf = conjugated base of ciprofloxacin) have been synthesised and characterised by elemental analyses, IR, NMR (1H, 19F and 13C CP-MAS) spectroscopy, as well as MS measurements. All spectroscopic data are consistent with the coordination of ciprofloxacin in all these complexes through the carbonyl and the carboxylate oxygen atoms with the formation of a six member chelate ring. The study of a Tc-ciprofloxacin solution by ESI-MS reveals the presence of [TcO(Cpf)2]+ cations, which agrees with the hypothesis that complexes 1 and 2 can be seen as model rhenium complexes of this radiopharmaceutical. Antimicrobial and DNA gyrase inhibition studies performed with complexes 2 and 3 have shown a very similar behaviour between complex 2 and the free antibiotic, whereas complex 3 exhibit a lower antimicrobial activity. Based on a joint analysis of the data reported in the literature and the chemical and biological results obtained in this study, a tentative proposal to explain some aspects of the behaviour of Tc-ciprofloxacin radiopharmaceutical has been made. © 2014 Elsevier Ltd. All rights reserved.
KW - Ciprofloxacin
KW - Infection
KW - Metal carbonyl
KW - Radiopharmaceutical
KW - Rhenium
KW - Technetium
UR - http://www.scopus.com/inward/record.url?scp=84901926050&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.bmc.2014.04.058
DO - https://doi.org/10.1016/j.bmc.2014.04.058
M3 - Article
C2 - 24853322
SN - 0968-0896
VL - 22
SP - 3262
EP - 3269
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 13
ER -